Insider · CIK 0001819718
Jian Xie
Files at FLGT (Fulgent Genetics, Inc.). First filing Nov 27, 2024, latest Sep 3, 2026.
Jian Xie files SEC Form 4 as COO and president at FLGT (Fulgent Genetics, Inc.). Since Nov 27, 2024, Jian Xie has reported 0 open-market buys worth $0 and 14 open-market sells worth $649k, the latest filed on Sep 3, 2026.
A track record needs three past buys with six months of prices behind them; Jian Xie has 0, so none is measured yet.
The newest scored trade: sold $42k of FLGT on Sep 2, 2026, filed Sep 3, 2026, scored 34 (weak). In the last 12 months: 0 buys worth $0 and 7 sells worth $481k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FLGT: Fulgent Genetics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | Fulgent Genetics, Inc. | $42k 2,127 shares | -1% | - | |
| 34Weak | Fulgent Genetics, Inc. | $38k 2,146 shares | -1% | +36% from low-39% from high | |
| 28Weak | Fulgent Genetics, Inc. | $21k 1,201 shares | -0% | +30% from low-42% from high | |
| 33Weak | Fulgent Genetics, Inc. | $32k 1,140 shares | -0% | +86% from low-8% from high | |
| 34Weak | Fulgent Genetics, Inc. | $35k 1,198 shares | -0% | +94% from low-4% from high | |
| 28Weak | Fulgent Genetics, Inc. | $21k 681 shares | -0% | +101% from low0% from high | |
| 42Moderate | Fulgent Genetics, Inc. | $291k 10,000 shares | -3% | +90% from low-2% from high | |
| 28Weak | Fulgent Genetics, Inc. | $25k 1,128 shares | -0% | +44% from low-4% from high | |
| 33Weak | Fulgent Genetics, Inc. | $26k 1,199 shares | -0% | +42% from low-6% from high | |
| 28Weak | Fulgent Genetics, Inc. | $15k 696 shares | -0% | +41% from low-6% from high | |
| 28Weak | Fulgent Genetics, Inc. | $23k 1,135 shares | -0% | +35% from low-10% from high | |
| 34Weak | Fulgent Genetics, Inc. | $38k 1,873 shares | -1% | +32% from low-12% from high | |
| 40Moderate | Fulgent Genetics, Inc. | $28k 1,455 shares | -0% | - | |
| 35Weak | Fulgent Genetics, Inc. | $13k 689 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 1, 2025 | FLGT FULGENT GENETICS, INC. | 1,135 0.00% of outstanding | $32k | Dec 2, 2025 | $372k |
| Nov 26, 2025 | FLGT FULGENT GENETICS, INC. | 1,198 0.00% of outstanding | $36k | Nov 28, 2025 | $377k |
| Nov 24, 2025 | FLGT FULGENT GENETICS, INC. | 681 0.00% of outstanding | $21k | Nov 24, 2025 | $357k |
| Nov 19, 2025 | FLGT FULGENT GENETICS, INC. | 10,000 0.03% of outstanding | $291k | Nov 19, 2025 | $66k |
| Sep 3, 2025 | FLGT FULGENT GENETICS, INC. | 1,128 0.00% of outstanding | $25k | Sep 3, 2025 | $41k |
| Aug 27, 2025 | FLGT FULGENT GENETICS, INC. | 1,199 0.00% of outstanding | $26k | Aug 27, 2025 | $76k |
| Aug 25, 2025 | FLGT FULGENT GENETICS, INC. | 696 0.00% of outstanding | $15k | Aug 25, 2025 | $61k |
| Jun 2, 2025 | FLGT FULGENT GENETICS, INC. | 1,135 0.00% of outstanding | $23k | Jun 2, 2025 | $38k |
| Dec 2, 2024 | FLGT FULGENT GENETICS, INC. | 1,483 0.00% of outstanding | $29k | Dec 2, 2024 | $48k |
| Nov 25, 2024 | FLGT FULGENT GENETICS, INC. | 689 0.00% of outstanding | $13k | Nov 25, 2024 | $51k |
Transactions
Every row this insider has filed, 44 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -2,127 | $19.66 | $42k | 359,924 | 40 d ago |
| Jun 2, 2026 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -2,146 | $17.89 | $38k | 367,605 | Jun 3, 2026 |
| May 27, 2026 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,201 | $17.60 | $21k | 369,751 | May 28, 2026 |
| Apr 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,361 | $16.31 | $71k | 370,952 | Apr 28, 2026 |
| Feb 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,140 | $24.76 | $28k | 384,539 | Mar 2, 2026 |
| Mar 1, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,079 | $15.33 | $17k | 383,460 | Mar 2, 2026 |
| Mar 1, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -8,147 | $15.33 | $125k | 375,313 | Mar 2, 2026 |
| Feb 23, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -655 | $23.01 | $15k | 331,383 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +5,862 | $0.00 | $0 | 337,245 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +15,299 | $0.00 | $0 | 352,544 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +27,341 | $0.00 | $0 | 379,885 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -3,163 | $23.09 | $73k | 376,722 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -8,254 | $23.09 | $191k | 368,468 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -14,751 | $23.09 | $341k | 353,717 | Feb 25, 2026 |
| Feb 24, 2026 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +31,962 | $0.00 | $0 | 385,679 | Feb 25, 2026 |
| Jan 26, 2026 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,711 | $27.53 | $130k | 332,038 | Jan 28, 2026 |
| Dec 2, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,140 | $28.33 | $32k | 336,749 | Dec 3, 2025 |
| Nov 28, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,198 | $29.57 | $35k | 337,889 | Dec 1, 2025 |
| Nov 24, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -681 | $30.47 | $21k | 339,087 | Nov 25, 2025 |
| Nov 19, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -10,000 | $29.10 | $291k | 349,768 | Nov 21, 2025 |
| Nov 19, 2025 | FLGT Fulgent Genetics, Inc. | GGift Common Stock | -10,000 | $0.00 | $0 | 339,768 | Nov 21, 2025 |
| Oct 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,353 | $23.74 | $103k | 359,768 | Oct 28, 2025 |
| Sep 3, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,128 | $22.03 | $25k | 364,121 | Sep 3, 2025 |
| Aug 27, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,199 | $21.48 | $26k | 365,249 | Aug 28, 2025 |
| Aug 25, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -696 | $21.50 | $15k | 366,448 | Aug 26, 2025 |
| Jul 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,352 | $18.37 | $80k | 367,144 | Jul 29, 2025 |
| Jun 2, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,135 | $20.29 | $23k | 371,496 | Jun 3, 2025 |
| May 27, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -690 | $20.58 | $14k | 373,814 | May 28, 2025 |
| May 27, 2025 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,183 | $20.52 | $24k | 372,631 | May 28, 2025 |
| Apr 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,353 | $18.88 | $82k | 374,504 | Apr 29, 2025 |
| Mar 1, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,481 | $15.45 | $23k | 378,857 | Mar 4, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +3,384 | $0.00 | $0 | 332,613 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +5,480 | $0.00 | $0 | 338,093 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +14,297 | $0.00 | $0 | 352,390 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -1,823 | $16.29 | $30k | 350,567 | Feb 27, 2025 |
| Feb 25, 2024 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -2,951 | $16.29 | $48k | 347,616 | Feb 27, 2025 |
| Feb 25, 2024 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -8,031 | $16.29 | $131k | 339,585 | Feb 27, 2025 |
| Feb 25, 2025 | FLGT Fulgent Genetics, Inc. | AGrant or award Common Stock | +45,304 | $0.00 | $0 | 384,889 | Feb 27, 2025 |
| Feb 26, 2024 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,551 | $16.24 | $74k | 380,338 | Feb 27, 2025 |
| Feb 23, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -719 | $16.46 | $12k | 329,229 | Feb 25, 2025 |
| Jan 26, 2025 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,733 | $17.21 | $81k | 329,948 | Jan 28, 2025 |
| Dec 3, 2024 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -1,455 | $19.50 | $28k | 334,681 | Dec 4, 2024 |
| Nov 25, 2024 | FLGT Fulgent Genetics, Inc. | SOpen-market sale Common Stock | -689 | $18.26 | $13k | 336,136 | Nov 27, 2024 |
| Oct 26, 2024 | FLGT Fulgent Genetics, Inc. | FTax withholding Common Stock | -4,345 | $19.42 | $84k | 336,825 | Oct 29, 2024 |
Questions about Jian Xie
Answered from the filings on this page, as of the latest one.
Is Jian Xie buying or selling?
In the last 12 months Jian Xie reported 0 open-market buys worth $0 and 7 open-market sells worth $481k on SEC Form 4; the latest was sold $42k of FLGT on Sep 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Jian Xie's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jian Xie has 0.
Where does Jian Xie file Form 4?
Jian Xie has filed Form 4 at FLGT (Fulgent Genetics, Inc.) as President and COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.